Information ahead of the extraordinary general meeting to be held on 27 March 2024
On 26 February 2024, Biokraft International AB (publ), reg.no 556528-4733 (“Biokraft” or the “Company”), announced the intention to resolve on a rights issue to finance repurchase of its senior secured green bonds (the “Rights Issue”). Due to this, the Company convened an extraordinary general meeting to be held on 27 March 2024, to, among other things, authorise the board of directors to resolve on the Rights Issue. In connection with the announcement, it was stated that the subscription price in the intended Rights Issue was expected to be determined no later than one day before the